Trial Profile
Safety of infliximab plus plasma exchange rescue therapy in patients with Kawasaki disease
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Dec 2015
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Mucocutaneous lymph node syndrome
- Focus Adverse reactions
- 11 Dec 2015 New trial record